Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has implemented its long-term incentive plan to its senior executives, including the CEO and CFO, along with share options for all employees. These awards are designed to encourage company growth and align staff interests with shareholders. The plan was first announced last November and later approved by 99.7% of shareholders at the company's AGM. For more information click here.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com